Coenzyme Q10 and α-lipoic acid supplementation in diabetic rats: Conduction velocity distributions

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 5, 2008, Pages 367-374

  Ayaz, Murat ^a   Tuncer, Seckin ^a   Okudan, Nilsel ^a   Gökbel, Hakki ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Lipoic acid; Coenzyme Q10; Conduction velocity distribution; Diabetic neuropathy

Indexed keywords

THIOCTIC ACID; UBIDECARENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DRUG MECHANISM; ELECTRODE; MALE; MITOCHONDRIAL RESPIRATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CONDUCTION; NERVE POTENTIAL; NEUROPROTECTION; NONHUMAN; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; TREATMENT DURATION; WAVEFORM;

ACTION POTENTIALS; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; INJECTIONS, INTRAPERITONEAL; KINETICS; MALE; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; THIOCTIC ACID; UBIQUINONE;

EID: 52649137489     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.5.1186072     Document Type: Article

References (32)

1. Vinik, A.I., Park, T.S., Stansberry, K.B., Pittenger, G.L. Diabetic neuropathies. Diabetologia 2000, 43(8): 957-73.
2. Ayad, H. Diabetic neuropathy: Classification, clinical manifestations, diagnosis and management. In: Diabetes Mellitus in Asia. Baba, S. et al. (Eds.). Excerpta Medica, Amsterdam, 1977, 222-4.
3. Feldman, E.L., Stevens, M.J., Russell, J.W., Greene, D.A. Somatosensory neuropathy. In: Ellenberg and Rifkin's Diabetes Mellitus. Porte, D. Jr., Sherwin, R.S., Baron, A. (Eds.). McGraw-Hill, New York, 2002, 771-88.
4. Feldman, E.L., Stevens, M.J., Russell, J.W., Greene, D.A. Diabetic neuropathy. In: Principles and Practice of Endocrinology and Metabolism. Becker, K.L. (Ed.). Lippincott Williams & Wilkins, Philadelphia, 2001, 1391-9.
5. Rodrigues Filho, O.A., Fazan, V.P. Streptozotocin-induced diabetes as a model of phrenic nerve neuropathy in rats. J Neurosci Methods 2006,151(2): 131-8.
6. Vinik, A.I. Diabetic neuropathy: Pathogenesis and therapy. Am J Med 1999,107: 17S-26S.
7. Cameron, N.E., Cotter, M.A. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997, 46: S31-7.
8. Yagihashi, S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 1995, 11(3): 193-225.
9. Sugimoto, K., Murakawa, Y., Sima, A.A. Diabetic neuropathy - A continuing enigma. Diabetes Metab Res Rev 2000, 16(6): 408-33.
10. Sima, A.A., Sugimoto, K. Experimental diabetic neuropathy: An update. Diabetologia 1999, 42(7): 773-88.
11. Van Dam, P.S., Van Asbeck, B.S., Erkelens, D.W., Marx, J.J.M., Gispen, W.H., Bravenboer, B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995, 11(3): 181-92.
12. Van Dam, P.S., Bravenboer, B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun 1997, 21: 41-8.
13. Greene, D.A., Stevens, M.J., Obrosova, I., Feldman, E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999, 375(1-3): 217-23.
14. Feldman, E.L. Oxidative stress and diabetic neuropathy: A new understanding of an old problem. J Clin Invest 2003, 111(4): 431-3.
15. Ayaz, M., Dalkilic, N., Bariskaner, H., Tuncer, S., Demirel, I. Gender-dependent effects of selenite on the perfused rat heart: A toxicological study. Biol Trace Elem Res 2007, 116(3): 301-10.
16. Ayaz, M., Kiziltan, E., Tuncer, S. et al. Sexual dependency of rat sciatic nerve fiber conduction velocity distributions. Int J Neurosci 2007, 117(11): 1537-49.
17. Pehlivan, F. Biyofizik (Biophysics). Ankara, Hacettepe-Tas Kitapcilik, 1997.
18. Ayaz, M., Dalkilic, N., Tuncer, S., Bariskaner, H. Selenium-induced changes on rat sciatic nerve fibers: Compound action potentials. Methods Find Exp Clin Pharmacol 2008, 30(4): in press.
19. Harayama, H., Shinozawa, K., Kondo, H., Miyatake, T. A new method to measure the distribution of motor conduction velocity in man. Electroencephalogr Clin Neurophysiol 1991, 81(5): 323-31.
20. Tamborlane, W.V., Ahem, J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am 1997, 44(2): 285-300.
21. Stevens, M.J., Obrosova, I., Cao, X., Van Huysen, C., Greene, D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 2000, 49(6): 1006-15.
22. Andersen, C.B., Henriksen, J.E., Hother-Nielsen, O., Vaag, A., Mortensen, S.A., Beck-Nielsen, H. The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin-dependent diabetes mellitus. Mol Aspects Mod 1997, 18(Suppl.): 307-9.
23. Modi, K., Santani, D.D., Goyal, R.K., Bhatt, P.A. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats. Biol Trace Elem Res 2006, 109(1): 25-34.
24. Zhang, Y., Turunen, M., Appelkvist, E.-L. Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of α-tocopherol into rat organs and cells. J Nutr 1996, 126(9): 2089-97.
25. Reahal, S., Wrigglesworth, J. Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration. Drug Metab Dispos 1992, 20(3): 423-7.
26. Kishi, T., Kishi, H., Watanabe, T., Folkers, K. Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus. I Med 1976, 7(3-4): 307-21.
27. McCarty, M.F. Maturity-onset diabetes - Toward a physiological appropriate management. Med Hypotheses 1981, 7(10): 1265-85.
28. Leinninger, G.M., Edwards, J.L., Lipshaw, M.J., Feldman, E.L. Mechanisms of disease: Mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2006, 2(11): 620-8.
29. Beal, M.F., Matthews, R.T. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol Aspects Med 1997, 18: 169-79.
30. Brouillet, E., Henshaw, D.R., Schulz, J.B., Beal, M.F. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10. Neurosci Left 1994, 177(1-2): 58-62.
31. Matthews, R.T., Yang, S., Browne, S., Baik, M., Beal, M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998, 95(15): 8892-7.
32. Ostrowski, R.P. Effect of coenzyme Q10 on biochemical and morphological changes in experimental ischemia in the rat brain. Brain Res Bull 2000, 53(4): 399-407.